The Japanese Society of Psychiatry and Neurology

Japanese
Award

Fellowship Award for the 118th Annual Meeting of the Japanese Society of Psychiatry and Neurology

Update: August 2, 2021

Application Guidelines

Application deadline: September 24th, 2021 (Japan Time)

The Japanese Society of Psychiatry and Neurology (JSPN) is now accepting applications for the JSPN Fellowship Award, which is presented to early-career psychiatrists from Asia and around the world. The purpose of this award is to recognize early-career, outstanding psychiatrists and to encourage academic discussion and personal friendships with early-career Japanese psychiatrists at the 118th annual meeting of the JSPN from June 16th to 18th, 2022, in Fukuoka, Japan.
The awardees and Japanese psychiatrists have collaborated to produce academic publications. Their achievements can be found here.

 

Eligibility

Applicants must:

1. Younger than 40 years of age or with 10 years or less experience in psychiatry 
2. Not be previous recipients of the JSPN Fellowship Award
3. Belong to a World Psychiatric Association member society
(To ensure broad participation from around the world, the JSPN accepts nominations from each society up to a maximum of two applicants.)

Note: Award recipients will receive a waiver of meeting registration fees, accommodation, and a prize (JPY 70,000 for recipients from World Bank A and B category countries, and JPY 140,000 for those from C and D category countries).

 

Award recipients will be expected to:

  • stay at a designated accommodation site
  • participate in the meeting for the three-day period
  • give a presentation at one of the Award symposia (on the topic for which the recipient applied)
  • attend other programs for JSPN Fellowship Award recipients

Award recipients will also be expected to participate in future JSPN Fellowship Award Alumni programs. They can carry out research about each theme in psychiatry with Japanese young psychiatrists and past Fellowship Awardees.

Applicants must choose one of the following four topics and submit an abstract of 200 - 250 words in length.

 

1.  Efforts to ensure continuity of psychiatric care under the COVID-19 pandemic

Under the COVID-19 pandemic, medical/psychiatric institutions had to introduce or strengthen measures to prevent the spread of infection (e.g., temperature measurement, disinfection, preventive equipment, screening of infection at the time of hospitalization, and questionnaires on behavioral history).  An increase in procedures and costs also took place to maintain the existing level of care. Various efforts seem to have been made, depending on the infection severity and the capacity of treatment or care for COVID-19 in the country (region).  

In this symposium, we would like to share the efforts that each country took to ensure continuity of psychiatric care so that we can prepare better for future responses.

Applicants are required to submit an abstract responding to the following questions.

(1) Give an overview of the COVID-19 pandemic in your country (region).

(2) How has psychiatric care changed in your country under the COVID-19 pandemic? How did psychiatric care change under the COVID-19 pandemic in your country? Discuss the increase or decrease of illness and the state of health care delivery.

(3) In your country, in response to the confinement to prevent the spread of COVID-19 infection, what mental health care measures have been taken in relation to patient visits and treatment (e.g., remote medical care)?

(4) Discuss the challenges of psychiatric care under the COVID-19 pandemic in your country and how the challenges have been addressed.


< PDF file

2. Mental health of healthcare workers under the COVID-19 pandemic

Treatment and care for the COVID-19 patients caused a huge burden for healthcare workers. In the event of the spread of the infection at a medical/psychiatric institution, responsibility for allowing the infection must have caused an immeasurable burden in addition to the burden to provide treatment. Psychiatric facilities have had to provide support to physical healthcare providers who are treating the COVID-19. Also, psychiatric facilities may have had to provide treatment directly to the COVID-19 positive patients. Thus psychiatry has had a wide range of roles.

In this symposium, we would like to share what kind of support psychiatry has provided to healthcare workers under the COVID-19 pandemic so that we can understand how to provide better support, now and also in the future.

Applicants are required to submit an abstract responding to the following questions.

(1) Give an overview of the COVID-19 pandemic in your country (region).

(2) What kind of medical system has been established for the COVID-19 in your country? (e.g., the establishment of a specialized ward)

(3) Describe a burden and problem among health care workers directly involved in the COVID-19 care in your country. (Occurrence of clusters in hospitals, exhaustion of health care workers, etc.)

(4) In your country, what kind of mental health care has been provided to health care workers directly involved in COVID-19 treatment? What results have you obtained?


< PDF file
 

3. Mental health of the general population under the COVID-19 pandemic: including a brief case description

The COVID-19 pandemic has caused a variety of changes in daily life around the world. The changes in daily life include legally based restrictions such as locking down cities and limiting the number of people at gatherings, and not legally based changes such as recommendation of working from home and discouragement of dining out and traveling.

There have been reports that individuals' mental health has been affected by these changes.

In this symposium, we want to gather knowledge on these restrictions on public mental health so that we can prepare better for future pandemics and other emergencies.

Applicants are required to submit an abstract summarizing the following issues related to psychiatric disorders or psychosocial problems that have increased under the COVID-19 pandemic.

(1) Give an overview of the COVID-19 pandemic in your country (region).

(2) Describe the psychiatric disorders and psychosocial problems noted to have increased under the COVID-19 pandemic in your country (region).

- Psychiatric disorders and psychosocial problems include both children and adults
- Psychosocial problems may include issues such as suicide, child abuse, domestic violence, etc.

(3) Case report: 1 case (brief description)


< PDF file

4. Efforts to maintain mental health in the general population under the COVID-19 pandemic

The COVID-19 pandemic has caused a variety of changes in daily life around the world. The changes in daily life include legally based restrictions such as locking down cities and limiting the number of people at gatherings, and not legally based changes such as recommendation of working from home and discouragement of dining out and traveling.

The mental health of individuals affected by these changes has been an important public health issue. 

The initiatives to maintain the mental health of individuals under the COVID-19 pandemic seem to include,
1.    public support measures led by government agencies (e.g., mental health awareness, hotlines, and focused abuse prevention campaigns)
2.    support measures led by the private sector and NGOs
3.    individual self-coping (e.g., yoga).

In this symposium, we want to gain knowledge on effective supports for mental health in the general population so that we can prepare better for future pandemics and other emergencies.

Applicants are required to submit an abstract responding to the following questions.

(1) Give an overview of the COVID-19 pandemic in your country (region).

(2) Describe concerns regarding the mental health of the general population in your country (region) under the COVID-19 pandemic and psychosocial problems such as suicide, child abuse, domestic violence, etc.

(3) Describe what kind of large-scale measures were taken to address these concerns for the general population and by what agencies and when under the COVID-19 pandemic. The entity can be any public or non-public organization.

- What efforts have been made to increase the effectiveness of support measures?
- If effectiveness and operational performance have been assessed, what were the results?

(4) Describe the individual-level stress-coping methods that were characteristically used under the COVID-19 pandemic.


< PDF file

 

Meeting information

The 118th Annual Meeting of the Japanese Society of Psychiatry and Neurology
Date June 16th – 18th, 2022
Venue

Fukuoka Convention Center  / Fukuoka Sunpalace

Meeting President Hiroaki Kawasaki (Professor, Department of Psychiatry, Faculty of Medicine, Fukuoka University)
Theme Psychiatric Perspectives of the Changing World and Minds

[important] According to the situation, please note that it is possible the annual meeting might be held online in case that it is not able to hold at the venue to prevent COVID-19 infection.

 

How to apply

We will start to accept an application from the beginning of August in 2021. Applicants must submit through On-Line Registration System below for the 118th annual Meeting of the Japanese Society of Psychiatry and Neurology.

On-Line Registration System
  1. “Personal information form”
    (The designated Excel form  must be used.   Example )
  2. “Nomination form” with signature of the president of the society as nominator
    (“Nomination form” could be of any format.   Example )
  3. Abstract of 200-250 words in length about topic 1 or 2 or 3 or 4

 

After your submission at On-Line Registration System, you will receive a confirmation e-mail.
Please contact the following Secretariat in case you do not receive the e-mail 30min. after your submission.
E-mail: jspn118@jtbcom.co.jp


Please note that JSPN does no longer accept any inquiries about your application from one week after the deadline .

Application deadline: September 24th, 2021 (Japan Time)

 

JSPN secretariat;
E-mail: jimu-kokusai@jspn.or.jp

To Top